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Abstract
Previous studies have demonstrated the influence of changes in the age at which women
give birth, and of developments in prenatal screening and diagnosis on the number of preg-
nancies diagnosed and terminated with chromosomal anomalies. However, we are unaware
of any population studies examining pregnancy terminations after diagnosis of chromo-
somal anomalies that has included all aneuploidies and the influence of maternal factors.
The aims of this study were to examine the association between results of prenatal tests
and pregnancy termination, and the proportion of foetuses with and without chromosomal
anomalies referred for invasive diagnostic tests over time. Diagnostic information of 26,261
prenatal invasive tests from all genetic service laboratories in Scotland from 2000 to 2011
was linked to Scottish Morbidity Records to obtain details on pregnancy outcome. Binary
logistic regression was carried out to test the associations of year and type of diagnosis with
pregnancy termination, while controlling for maternal age, neighbourhood deprivation and
parity. There were 24,155 (92.0%) with no chromosomal anomalies, 1,483 (5.6%) aneu-
ploidy diagnoses, and 623 (2.4%) diagnoses of anomaly that was not aneuploidy (including
translocations and single chromosome deletions). In comparison with negative test results,
pregnancies diagnosed with trisomy were most likely to be terminated (adjusted OR 437.40,
95% CI 348.19–549.46) followed by other aneuploid anomalies (adjusted OR 95.94, 95% CI
69.21–133.01). During the study period, fewer pregnancies that were diagnosed with aneu-
ploidy were terminated, including trisomy diagnoses (adjusted OR 0.44, 95% CI 0.26–0.73).
Older women were less likely to terminate (OR 0.35, 95% CI 0.28, 0.42), and parity was also
an independent predictor of termination. In keeping with previous findings, while the number
of invasive diagnostic tests declined, the proportion of abnormal results increased from
6.09% to 10.88%. Systematic advances in prenatal screening have improved detection
rates for aneuploidy. This has been accompanied by a reduction in the rate of termination
for aneuploidy. This may reflect societal changes with acceptance of greater diversity, but
this is speculation, and further research would be needed to test this.
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Introduction
The age at which women give birth has increased progressively in many high income coun-
tries, such that in Scotland, the proportion of mothers giving birth at age 35 or over has
increased from 14.9% in 2000 to 19.7% in 2011 [1]. Reflecting the recent changes in maternal
demographics and that maternal age increases the likelihood of foetal aneuploid chromosomal
anomalies, including Edwards, Patau, Klinefelter and Triple X syndromes, and the commonest
type, Down syndrome [2], the number of aneuploid pregnancies has increased [3, 4]. Detec-
tion rates have also increased, as prenatal screening and diagnostic techniques for chromo-
somal anomalies have become more widely available and more sensitive [5–7]. In England and
Wales, among mothers younger than 37 years the proportion of prenatal aneuploid diagnoses
increased from 3% in 1989 to 43% in 2008, whilst this proportion remained at 70% for mothers
aged 37 or older [3]. Similar trends have been reported in Victoria, Australia and in Denmark
[8, 9].
Recent systematic reviews of factors, which may influence the decision to terminate or con-
tinue the pregnancy, have reported inconsistent results. With respect to maternal age, studies
have reported increased likelihood of termination for Down syndrome in both younger and
older women, as well as no association with age [10, 11]. Similarly, a systematic review on deci-
sions to terminate pregnancies following diagnosis of sex chromosome abnormalities found
no relationship with maternal age [12]. Two studies examined this for a wider range of chro-
mosome abnormalities [13, 14]. While Drugan et al. (1990) found no difference in the age of
women who did and did not terminate [13], Shaffer et al., (2006) concluded that the effect of
age may be dependent on the diagnosis; with older women being more likely to terminate a
pregnancy affected by trisomy but less likely to terminate after a diagnosis of sex chromosome
abnormality [14].
With respect to parity, an association has been demonstrated between parity and the
decision to terminate for Down syndrome [15] but the results are inconsistent in relation to
termination decisions for sex chromosome anomalies [12]. Two studies examined previous
obstetric history for a wider range of chromosome abnormalities and found that while the
number of previous livebirths and spontaneous abortions did not differ between women who
did and did not terminate, history of previous terminations increased the likelihood of termi-
nation of the current pregnancy [13, 16].
Whilst the evidence in relation to maternal characteristics and past obstetric history is
inconclusive, the actual diagnosis has been found to be more clearly related to the decision to
terminate. Trisomy, including Down syndrome, is associated with higher termination rates
than sex chromosome abnormalities [14, 16–18]. Furthermore, of the sex chromosome abnor-
malities, Turner syndrome and Klinefelter syndrome have higher termination rates than Triple
X or 47,XYY [12]. Abnormal ultrasound findings identified either before or after the diagnosis
of chromosome abnormalities (including trisomy, sex chromosome abnormalities, and bal-
anced and unbalanced translocations) have been found to further increase the likelihood of
pregnancy termination [13, 19].
In spite of increasing maternal age and increasing detection rates of chromosomal anoma-
lies, termination rates have been reported as remaining stable over the last decade in both sin-
gle centre and population studies [3, 8, 14]. However, we are unaware of any population study
that has included all aneuploidies and studied the influence of maternal factors and specific
prenatal diagnoses on termination rates. To address this, we used Scotland wide data to exam-
ine whether there have been changes over time in the proportion of pregnancies affected with
and without chromosomal anomalies who are referred for invasive diagnostic tests and the
Pregnancy Outcome following Prenatal Diagnosis
PLOS ONE | DOI:10.1371/journal.pone.0166909 December 1, 2016 2 / 11
Funding: The study was funded by a grant from
the Scottish Government (http://www.gov.scot/)
awarded to SAC; Grant number: 60559 (Scottish
Learning Disabilities Observatory). The funders had
no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
proportion of pregnancies associated with chromosomal anomalies that are terminated. We
also examined whether termination rates differed by prenatal diagnosis.
Materials and Methods
Data sources
The study cohort comprised all pregnancies during which genetic testing had been undertaken
from January 2000 to December 2011 inclusive, in four NHS regional genetic services (Glas-
gow, Edinburgh, Aberdeen, Dundee), covering the total population in Scotland. A service was
also provided in Inverness until 2010 when Aberdeen took over its cases. Chorionic villus sam-
pling or amniocentesis (depending upon gestational stage) was used to collect foetal cells for
prenatal diagnosis via karyotyping, fluorescence in situ hybridization (FISH), or quantitative
fluorescence polymerase chain reaction (QF-PCR). Reasons for referral to genetic counselling
services included advanced maternal age, an abnormal ultrasound scan, a high-risk biochemis-
try result, family history of chromosomal abnormalities and maternal anxiety about having an
abnormal pregnancy. Ultrasound scans and biochemistry tests are part of the pregnancy
screening that is offered to all pregnant women in Scotland.
The screening programmes offered in Scotland were standardised from 2001 to a second
trimester blood sample test for Down syndrome and neural tube defects using two serum
markers [20]. Further changes were made in 2008 [21] to a first trimester screen for Down syn-
drome comprising blood biomarkers combined with ultrasound measurement of foetal nuchal
translucency; a second trimester foetal anomaly ultrasound examination; and a second trimes-
ter screen with quadruple markers, for those women who did not present early enough for the
first trimester screening. In 2011, the cut off for a high-risk screening result was changed to 1
in 150 from 1 in 250 for the combined first trimester screen and from 1 in 220 for the second
trimester quadruple screening. This was in order to achieve a sensitivity of greater than 90%
and a screen positive rate (i.e. the total percentage of abnormal results) of less than 2% for the
combined first trimester screen, and a sensitivity of more than 75% and a screen positive rate
of less than 3% for the second trimester quadruple screening [22]. Women with screening
results indicative of high risk are referred for further invasive diagnostic tests, i.e. chorionic vil-
lus sampling or amniocentesis.
Data were provided by all the genetic service laboratories in Scotland. These included the
month and year of investigation, diagnostic test results, and pregnancy outcome if known.
Year of investigation was categorised into: 2000–2003, 2004–2007 and 2008–2011. Diagnoses
were grouped into three main categories: aneuploidy, other anomaly, and normal. Aneuploidy
comprised Down syndrome, Edwards syndrome, Patau syndrome, Turner syndrome, Klinefel-
ter syndrome, triple X, 47 XYY, triploidy and tetraploidy. In the secondary analyses, the aneu-
ploid karyotypes were further categorised into two sub-groups: trisomy 21, 18, or 13 (Down
syndrome, Edwards syndrome, Patau syndrome, but not triple X nor XXY) and other aneu-
ploid anomalies (Turner syndrome, Klinefelter syndrome, Triple X, 47 XYY, Triploidy and
Tetraploidy). The ‘other anomaly’ category consisted of all other abnormal results, including
balanced and unbalanced (Robertsonian and reciprocal) translocations, and single chromo-
some deletions, inversions and variants.
The data from the genetic service laboratories were linked, at an individual level, using the
Community Health Index (a unique personal identifier) to two Scotland-wide health adminis-
trative databases routinely collected and centrally collated as part of the Scottish Morbidity
Record (SMR). SMR01 collects data on all acute hospital admissions and day cases including
disease codes and the SMR02 maternity records collect data on all discharges from obstetric
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units in Scotland, including details of live births and stillbirths, and maternal age, marital sta-
tus, parity, and the Scottish Index of Multiple Deprivation (SIMD) [23].
Permission to access, link and analyse these data was granted by the Privacy Advisory Com-
mittee (PAC) to the National Health Service (NHS) National Services Scotland (NSS) and the
Registrar General. Written informed consent was not obtained from participants for their clin-
ical records to be used in this study, but patient records were anonymized and de-identified
prior to analysis.
Data
SIMD is an area-based measure of socioeconomic deprivation derived for postcode of resi-
dence (mean population 800) using Census data on 7 domains: employment, income, health,
education, access to services, crime, and housing [23]. The index is categorised into quintiles
for the general population ranging from 1 (least affluent) to 5 (most affluent). The maternal
postcode of residence, recorded on SMR01 or SMR02, is then used to allocate the mother and
her offspring to an SIMD quintile. Maternal age was provided in years and coded into 5 cate-
gories: <25, 25–29, 30–34, 35–39,40. Marital status was categorised as married, never mar-
ried, widowed/ divorced, and not known. Parity was defined as the number of previous
pregnancies resulting in a live birth or stillbirth and coded into three categories: 0, 1, and 2.
SMR02 records provide pregnancy outcome as livebirth and stillbirth (i.e. baby born dead
after 24 weeks gestation), and distinguish between therapeutic abortion, spontaneous, incom-
plete and missed abortion (i.e. baby dies before 24 weeks gestation), trophoblastic disease, and
other and unspecified abortion. SMR01 records contain ICD-10 disease codes and were used
to identify any therapeutic abortions (O04) and spontaneous, incomplete and missed abor-
tions (O02-03) in women without an SMR02 record. Other abortions, unspecified abortions,
trophoblastic disease and other abnormal products of conception were grouped as ‘other out-
comes’. The remaining outcomes were then categorised into pregnancies ending in therapeutic
abortion, and those that did not. The latter included livebirths, stillbirths, and spontaneous,
incomplete and missed abortions.
Statistical analyses
Multiple pregnancies were identified and excluded. Cross tabulations and Pearson’s chi-
squared tests were employed to compare the characteristics of the prenatal diagnostic groups.
Binary logistic regression was undertaken to determine whether year and diagnosis were asso-
ciated with termination of pregnancy and whether any associations were independent of
maternal age, parity and SIMD. Interactions of year with maternal age, parity and SIMD were
also examined. Results are presented as unadjusted and adjusted odds ratios with 95% confi-
dence intervals (CI). All analyses were carried out in SPSS 22.
Results
Data were available on 26,594 prenatal diagnostic tests. Following exclusion of 281 multiple
pregnancies and 52 where the diagnostic result was not recorded, the study sample comprised
26,261 pregnancies. The distribution across the genetic laboratories reflected the sizes of their
catchment populations: Glasgow 43.4%; Edinburgh 26.9%; Aberdeen 14.0%; Tayside 12.0%;
and Highland 3.6%. The most common reason for referral to the genetic services was a high
risk screening result: high risk biochemistry 57.8%; and an abnormal scan (11.6%). Other rea-
sons included: advanced maternal age 20.1%; family history of chromosomal abnormalities
6.6%; maternal anxiety 2.8%; and in-vitro fertilization 1.1%. Overall, 24,155 (92.0%) tests
revealed no detectable chromosomal anomaly, 1,483 (5.6%) aneuploidy, and 623 (2.4%)
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another anomaly (a very heterogenous group, of which 111 were balanced translocations, 51
Robertsonian translocations, and a number of single chromosomal deletions and inversions).
Aneuploidy included 851 (57.4%) with Down syndrome, 302 (20.4%) Edwards syndrome, 93
(6.3%) Patau syndrome, 122 (8.2%) Turner syndrome, 25 (1.7%) Klinefelter syndrome, 17
(1.1%) triple X, 8 (0.5%) 47XYY, and 65 (4.4%) triploidy or tetraploidy. The characteristics of
patients differed significantly according to the prenatal diagnosis (Table 1). The proportion of
tests with a positive result increased over time (Table 1). Overall, anomalies were more com-
mon among mothers who were younger, less affluent, and who had lower parity. In contrast,
Table 1. Characteristics of study participants by test result.
All tests Aneuploidy
Normal (n = 24,155) Aneuploidy
(n = 1483)
Other anomaly
(n = 623)
P-value* Trisomy1
(n = 1,246)
Other
aneuploid
anomaly2
(n = 237)
P-value*
n % n % n % n % n %
Year of test
2000–2003 8,810 93.7 402 4.3 188 2.0 <.001 331 82.3 71 17.7 .256
2004–2007 8,264 91.8 539 6.0 197 2.2 452 83.9 87 16.1
2008–2011 6,957 90.1 534 6.9 232 3.0 455 85.2 79 14.8
Missing 124 8 6 8 0
Maternal age (years)
<25 1,285 90.0 93 6.5 49 3.4 <.001 57 61.3 36 38.7 <.001
25–29 1,981 90.4 130 5.9 81 3.7 82 63.1 48 36.9
30–34 4,941 93.0 233 4.4 138 2.6 188 80.7 45 19.3
35–39 9,445 94.4 398 4.0 166 1.7 357 89.7 41 10.3
40 4,720 92.5 294 5.8 89 1.7 267 90.8 27 9.2
Missing 1,783 335 100 295 40
SIMD quintile
1 (least affluent) 2,926 92.2 168 5.3 80 2.5 .045 121 72.0 47 28.0 <.001
2 3,429 92.8 187 5.1 80 2.2 148 79.1 39 20.9
3 4,228 93.8 203 4.5 78 1.7 174 85.7 29 14.3
4 5,427 93.4 273 4.7 111 1.9 233 85.3 40 14.7
5 (most affluent) 6,287 92.9 312 4.6 171 2.5 270 86.5 42 13.5
Missing 1,858 340 103 300 40
Marital status
Married 10,377 93.2 524 4.7 235 2.1 .550 449 85.7 75 14.3 .001
Never married 4,196 92.5 235 5.2 103 2.3 176 74.9 59 25.1
Widowed/divorced 1,271 92.6 74 5.4 27 2.0 62 83.8 12 16.2
Missing 8,311 650 258 559 91
Parity
0 7,751 92.4 417 5.0 219 2.6 .006 328 78.7 89 21.3 .003
1 8,218 93.5 403 4.6 168 1.9 337 83.6 66 16.4
2 6,152 93.3 315 4.8 126 1.9 274 87.0 41 13.0
Missing 2,034 348 110 307 41
n, number; SIMD, Scottish Index of Multiple Deprivation.
1Down, Edwards and Patau syndrome.
2Turner syndrome, Klinefelter syndrome, Triple X, 47 XYY, Triploidy and Tetraploidy.
*p values were calculated using the χ2 test; χ2 for trend test was used for 2*n ordinal data.
doi:10.1371/journal.pone.0166909.t001
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among the sub-group diagnosed with aneuploidy, trisomy 21, 18 or 13 was more common
among mothers who were older, more affluent, married, and who had higher parity.
Table 2 contains the results of the binary logistic regression models undertaken to examine
changes in the use of termination over time. Overall, terminations became significantly more
common over the three time periods: 2004–2007 (OR 1.26, 95% CI 1.11–1.43, p<0.001) and
2008–2011 (OR 1.35, 95% CI 1.19–1.53, p<0.001) in comparison to 2000–2003 (p< .001 for
overall effect). However, there were significant interactions between year of diagnosis and type
of diagnosis, maternal age, SIMD quintile and parity (all p<0.001). On sub-groups analysis
(Table 2), terminations decreased over time following diagnosis of aneuploidy even after
adjustment for potential confounders, but increased significantly for other anomalies. For the
women whose pregnancy did not have a chromosomal anomaly, terminations rates were 1.7%
in 2000–2003, 2.1% in 2004–2007, and 2.0% in 2008–2011.
When the univariate model was re-run including only pregnancies in which trisomy was
diagnosed, termination rates fell significantly over time: 2004–2007 (OR 0.44, 95% CI 0.27–
0.72, p = 0.001) and 2008–2011 (OR 0.41, 95% CI 0.25–0.67, p<0.001) in comparison to 2000–
2003 (p = .001 for overall effect). Adjustment for maternal age, SIMD and parity did not alter
the results: 2004–2007 (adjusted OR 0.40, 95% CI 0.24–0.66, p<0.001) and 2008–2001 (OR
Table 2. Binary Logistic Regression for the Association between Year and Termination for the Full Sample.
Univariate Multivariate1
2000–
2003
2004–2007 OR
(95% CI) P-value
2008–2011 OR
(95% CI) P-value
P-
value
2000–
2003
2004–2007 OR
(95% CI) P-value
2008–2011 OR
(95% CI) P-value
P-
value
Diagnosis Normal
chromosomes
1.00 1.26 (1.00–1.59)
.047
1.24 (0.97–1.58)
.081
.097 1.00 1.32 (1.02–1.72)
.043
1.21 (0.91–1.60)
.186
.122
Aneuploidy 1.00 0.54 (0.37–0.79)
.002
0.55 (0.37–0.81)
.003
.003 1.00 0.50 (0.33–0.74)
.001
0.57 (0.38–0.86)
.007
.002
Other anomaly 1.00 1.83 (1.10–3.04)
.019
2.04 (1.25–3.33)
.004
.012 1.00 2.33 (1.30–4.16)
.004
2.62 (1.50–4.58)
.001
.002
Age <35 1.00 1.20 (0.99–1.46)
.062
1.20 (0.98–1.45)
.074
.109 1.00 1.15 (0.89–1.48)
.293
1.12 (0.86–1.45)
.400
.538
35 1.00 1.39 (1.14–1.68)
.001
1.66 (1.37–2.02) <
.001
<.001 1.00 0.99 (0.72–1.36)
.940
1.08 (0.78–1.49)
.663
.856
SIMD 1 (least affluent) 1.00 1.07 (0.75–1.54)
.694
1.28 (0.90–1.81)
.167
.352 1.00 0.79 (0.49–1.27)
.333
1.04 (0.66–1.63)
.859
.454
2 1.00 1.49 (1.06–2.09)
.021
1.74 (1.24–2.43)
.001
.005 1.00 1.25 (0.77–2.05)
.365
1.38 (0.86–2.24)
.187
.409
3 1.00 0.90 (0.64–1.26)
.539
1.05 (0.75–1.45)
.791
.681 1.00 0.86 (0.52–1.43)
.561
0.95 (0.58–1.57)
.842
.841
4 1.00 1.06 (0.80–1.42)
.671
1.33 (1.00–1.77)
.051
.123 1.00 1.10 (0.71–1.71)
.679
0.89 (0.56–1.40)
.604
.659
5 (most affluent) 1.00 1.76 (1.37–2.27) <
.001
1.65 (1.26–2.18) <
.001
<.001 1.00 1.44 (0.98–2.12)
.066
1.41 (0.93–2.12)
.105
.136
Parity 0 1.00 1.36 (1.10–1.69)
.005
1.32 (1.05–1.64)
.015
.012 1.00 1.27 (0.93–1.73)
.136
1.19 (0.87–1.64)
.281
.310
1 1.00 1.44 (1.15–1.82)
.002
1.46 (1.15–1.86) .002 1.00 1.33 (0.94–1.87)
.110
1.29 (0.91–1.84)
.159
.222
2 1.00 0.89 (0.67–1.18)
.409
1.57 (1.21–2.05)
.001
<.001 1.00 0.66 (0.43–1.00)
.049
0.88 (0.59–1.32)
.543
.135
OR odds ratio; CI confidence interval; SIMD, Scottish Index of Multiple Deprivation.
1Adjusted for Diagnosis, Maternal age, SIMD quintiles, Parity.
doi:10.1371/journal.pone.0166909.t002
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0.44, 95% CI 0.26–0.73, p = 0.002) in comparison to 2000–2003 (p = .001 for overall effect).
There were no statistically significant interactions.
The percentage of pregnancies that were terminated varied significantly by diagnosis:
85.2% for trisomy, 65.4% for other aneuploid anomalies and 1.9% for normal karyotypes
(χ2 (2) = 13283.00, p< .001). After adjustment for year of testing, maternal age, SIMD quintile
and parity, diagnosis remained a significant predictor of termination. In comparison with nor-
mal chromosomal test results, termination was significantly most likely following a diagnosis
of trisomy 21, 18, or 13 (adjusted OR 437.40, 95% CI 348.19–549.46, p<0.001) and other aneu-
ploidy anomalies (adjusted OR 95.94, 95% CI 69.21–133.01, p<0.001). Older women were less
likely to terminate their pregnancy (OR 0.35, 95% CI 0.28, 0.42). Parity was a significant inde-
pendent predictor of termination (Table 3)
Ascertainment of prenatal screening
Between 2000 and 2011, the total number of invasive diagnostic tests carried out each year
decreased from 2,447 to 1,655. However, the number of diagnoses made each year of aneu-
ploidy and other anomalies has increased gradually from 149 to 180 (see Fig 1), resulting in an
increase in the percentage of all abnormal karyotypes detected amongst those who were
referred for diagnostic testing from 6.09% to 10.88%. This indicates that, over the study period,
the positive predictive value of screening procedures has improved as fewer foetuses with nor-
mal karyotypes were considered as high risk and referred for prenatal diagnostic testing.
Table 3. Independent predictors of pregnancy outcomes.
Predictor Univariate Adjusted1
Odds ratio 95% CI P-value Odds ratio 95% CI p-value
Diagnosis <.001 <.001
Normal chromosomes 1 1
Aneuploidy 304.50 250.98–369.44 <.001 437.40 348.19–549.46 <.001
Other anomaly 97.00 72.43–129.91 <.001 95.94 69.21–133.01 <.001
Year <.001 .972
2000–2003 1 1
2004–2007 1.27 1.12–1.44 <.001 0.98 0.79–1.22 .874
2008–2011 1.37 1.20–1.55 <.001 0.97 0.78–1.22 .815
Age
<35 1 1
35 0.59 0.53–0.65 <.001 0.35 0.28–0.42 <.001
SIMD .001 .221
1 (least affluent) 1 1
2 0.98 0.81–1.18 .822 1.24 0.91–1.70 .174
3 0.73 0.60–0.88 .001 0.88 0.64–1.21 .434
4 0.77 0.64–0.92 .003 0.99 0.73–1.34 .934
5 (most affluent) 0.84 0.71–0.99 .040 1.10 0.82–1.47 .538
Parity .037
0 1 1
1 0.81 0.72–0.92 .001 0.86 0.70–1.06 .159
2 0.79 0.69–0.90 .001 0.73 0.58–0.93 .011
CI confidence interval; SIMD Scottish Index of Multiple Deprivation.
1Adjusted for diagnosis, year of testing, maternal age, SIMD quintiles, parity
doi:10.1371/journal.pone.0166909.t003
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Discussion
Principal findings
Overall, the likelihood of a diagnosis of aneuploidy resulting in a decision to terminate the
pregnancy has fallen over time. However, the use of termination varies greatly within the aneu-
ploidy group. A diagnosis of trisomy is more likely to result in termination, perhaps due to the
more serious health implications. It is likely that the temporal trend we observed predates our
study period, as our trisomy pregnancy termination rate of 85% compares with a previous
Scottish report in the 1990s of 97.3% for Down syndrome, 85.9% for trisomy 18, and 90.0% for
trisomy 13 [24]. Our results may indicate that society is becoming more accepting of diversity
and people with disabilities, or that support is more readily available for affected parents and
offspring. People with Down syndrome are considerably more visible in Scottish society now
than in the era of the long-stay intellectual disabilities hospitals. However, this interpretation is
of course purely speculative, and a study using qualitative research methods would be neces-
sary to test if these factors explain the trend we have identified. Conversely, although rarer dis-
orders, terminations for other (non-aneuploidy) anomalies have increased over the study
period. These other conditions, such as balanced and unbalanced translocations, single chro-
mosome deletions, inversions and variants may have milder, more variable and less certain
phenotypes compared to the aneuploidies, and it is possible that this influences decision-mak-
ing on termination.
Previous research provided the contrary findings that termination rates were stable over
time for aneuploid diagnoses in Australia, England and Wales, and in the USA [3, 8, 14]. How-
ever, these studies covered earlier time periods, namely the 1980s, 1990s, and early 2000s, and
patterns of termination may differ between countries. Indeed, the termination rate we report
for the period of 2000–2011 of 85.2% for trisomy pregnancies is lower than the latest rates in
England and Wales of 90.1% for Down syndrome, 92.7% for Edwards syndrome and 90.3% for
Patau syndrome [25].
Fig 1. Ascertainment of prenatal screening.
doi:10.1371/journal.pone.0166909.g001
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We found that older women were markedly less likely to terminate, and also found that
parity was an independent predictor of termination, whereas neighbourhood deprivation
was not.
Religion is likely to play a role in decisions around pregnancy termination [10, 26]. How-
ever, the Census in Scotland shows that the proportion of the population that identified them-
selves as not religious increased from 28% in 2001 to 37% in 2011 [27, 28]. The counselling
process after a diagnosis may also impact on the decision to terminate [12, 16]. In a systematic
review focussing on termination decisions after a diagnosis of a sex chromosome abnormality,
Jeon et al. (2012) found that women who were counselled by non-geneticists were more likely
to terminate the pregnancy and those who were counselled by a genetic specialist were less
likely to terminate [12]. In Scotland counselling is provided by obstetricians, frequently with
the input of clinical genetics. In addition, those who experienced more directive counselling
were more likely to terminate, and those who experienced less directive counselling were less
likely to terminate. Uptake of a second genetic counselling session was related to a lower likeli-
hood to terminate the pregnancy following diagnosis of trisomy or sex chromosome abnor-
mality [16].
A number of studies have found a relationship between earlier gestation at diagnosis and
greater likelihood to terminate the pregnancy [11, 15]. Drugan et al. (1990) explained that ter-
mination later in the pregnancy may be more difficult as bonding may be stronger and pres-
sures from society, family and friends may influence the decision [13]. Earlier in the
pregnancy, the decision to terminate may be more private and the process may be less emo-
tionally damaging. The introduction of first trimester screening in Scotland in 2008 may have
decreased the average gestational age at which women receive a prenatal diagnosis, however,
we did not test this in this study.
In keeping with previous reports, pregnancies diagnosed with trisomy remained more likely
to be terminated than pregnancies diagnosed with other aneuploid anomalies [14, 16–18].
Also in keeping with previous findings, our study also shows that the total number of invasive
diagnostic tests decreased over the study period, while the proportion of those undertaken that
had an abnormal result increased. This shows that the changes to prenatal screening made in
Scotland have improved the positive predictive value of prenatal screening.
Strengths and weaknesses
This is the first non-selective, population based study in Scotland examining pregnancy termi-
nations after prenatal diagnosis of chromosomal anomalies. It took account of potential con-
founders such age, SIMD and parity. It was not subject to selection bias, as the study was based
on routine data sources from all genetic service laboratories in Scotland. We had access to
both SMR-02 maternity records and SMR-01 hospital admissions to ascertain pregnancy out-
come, thereby improving completeness. The outcome could not be determined for only 7.3%
of the pregnancies. This is likely to be because of admission to a hospital outside of Scotland or
the NHS.
In order to protect anonymity, the current study could not report data on individual diag-
nostic groups, as the groups were too small. There was a large amount of missing data for
marital status which was therefore not controlled for in the analyses. Marital status however
is closely related to age and SIMD, which were both included. In addition, we did not have
access to information on religion. Years were collapsed into groups of three to avoid having
too many predictors and reduced power, especially for analyses that excluded normal karyo-
types. Therefore, detailed information regarding year to year changes over time may have
been lost.
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Conclusions
In Scotland, termination rates for trisomy are higher than for other aneuploidy, but rates for
both have fallen over time. This may be linked to societal changes in accepting greater diver-
sity, but further research would be needed to test this. Older women were less likely to termi-
nate. In keeping with previous findings, screening procedures are now better at identifying
those pregnancies in which the diagnosis will be positive therefore fewer pregnancies with nor-
mal karyotypes are undergoing prenatal invasive diagnostic tests, which have a risk of proce-
dure related miscarriage. Recent developments in non-invasive prenatal testing may improve
this further.
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